in vivo :
Search Words
News & Articles
- Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7; first in vivo study of the treatment ...
The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms. Researchers believe that their results show that a clinical trial in humans is merited.
June 10, 2013 - Science Daily - Doing More With Less – 2009 AAPS Annual Meeting and Exposition
The annual AAPS show is always a good barometer of the life sciences industry. Few other events offer such a large representation of all facets of the drug development cycle. This year’s hot topics included: biosimiliars, PEGylation, pharmacogenomics, in vivo targeting, and global counterfeiting as well as multiple discussions around advancements in personalized medicine.
June 10, 2013 - PharmaceuticalOnline - Interferon-beta aids balance and movement in mice with spinocerebellar ataxia 7
The first in vivo trial of the use of interferon-beta in a mouse model of the group of fatal diseases known as spinocerebellar ataxia has shown that its use can significantly improve their physical condition and control symptoms. Researchers in France and the US believe that their results show that a clinical trial in humans is merited.
June 9, 2013 - EurekAlert!